← All organizations
Highest phase reached
Phase 2
First clinical trial
Jul 1, 2005Last known activity
Oct 12, 2021
Timeline
1950s
- Jun 1, 1953
Cancer Research Institute— Founded
Drugs by trial phase (30 distinct, 20 trials)
Phase 2 (21 own, 0 via acquisition)
Phase 1 (9 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Appendiceal Neoplasms
- Carcinoma
- Carcinoma, Merkel Cell
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Glioblastoma
- Kidney Neoplasms
- Lung Neoplasms
- Lymphoma, T-Cell, Cutaneous
- Melanoma
- Multiple Myeloma
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Second Primary
- Ovarian Neoplasms
- Prostatic Neoplasms
- Squamous Cell Carcinoma of Head and Neck
- Testicular Neoplasms
Recent trials (20)
- NCT04918186CollaboratorPhase 2Oct 12, 2021
- NCT04787991CollaboratorPhase 1Aug 9, 2021
- NCT04093167CollaboratorPhase 2Sep 30, 2019
- NCT03835533CollaboratorPhase 1Jun 30, 2019
- NCT03461952CollaboratorPhase 2Sep 30, 2018
- NCT03651271CollaboratorPhase 2Sep 14, 2018
- NCT03214250CollaboratorPhase 1/Phase 2Jul 21, 2017
- NCT03164772CollaboratorPhase 1/Phase 2Jul 1, 2017
- NCT02898116CollaboratorPhase 1/Phase 2Mar 1, 2017
- NCT02963831CollaboratorPhase 1/Phase 2Jan 1, 2017
- NCT02643303CollaboratorPhase 1/Phase 2Dec 28, 2016
- NCT02716805CollaboratorPhase 1Nov 1, 2016
- NCT02431559CollaboratorPhase 1/Phase 2Nov 1, 2015
- NCT02425306CollaboratorPhase 1/Phase 2May 1, 2015
- NCT02336165CollaboratorPhase 2Feb 26, 2015
Details
- Founded
- New York, NY, US Jun 1, 1953
- Last known activity
- Oct 12, 2021